Cargando…

Patients’ preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study

BACKGROUND AND PURPOSE: The German Institute for Quality and Efficiency in Health Care (IQWiG) previously tested two preference elicitation methods in pilot projects and regarded them as generally feasible for prioritizing outcome-specific results of benefit assessment. The present study aimed to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vennedey, Vera, Derman, Sonja HM, Hiligsmann, Mickaël, Civello, Daniele, Schwalm, Anja, Seidl, Astrid, Scheibler, Fülöp, Stock, Stephanie, Noack, Michael J, Danner, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248230/
https://www.ncbi.nlm.nih.gov/pubmed/30510407
http://dx.doi.org/10.2147/PPA.S176067
_version_ 1783372597931540480
author Vennedey, Vera
Derman, Sonja HM
Hiligsmann, Mickaël
Civello, Daniele
Schwalm, Anja
Seidl, Astrid
Scheibler, Fülöp
Stock, Stephanie
Noack, Michael J
Danner, Marion
author_facet Vennedey, Vera
Derman, Sonja HM
Hiligsmann, Mickaël
Civello, Daniele
Schwalm, Anja
Seidl, Astrid
Scheibler, Fülöp
Stock, Stephanie
Noack, Michael J
Danner, Marion
author_sort Vennedey, Vera
collection PubMed
description BACKGROUND AND PURPOSE: The German Institute for Quality and Efficiency in Health Care (IQWiG) previously tested two preference elicitation methods in pilot projects and regarded them as generally feasible for prioritizing outcome-specific results of benefit assessment. The present study aimed to investigate the feasibility of completing a discrete choice experiment (DCE) within 3 months and to determine the relative importance of attributes of periodontal disease and its treatment. PATIENTS AND METHODS: This preference elicitation was conducted alongside the IQWiG benefit assessment of systematic treatments of periodontal diseases. Attributes were defined based on the benefit assessment, literature review, and patients’ and periodontologists’ interviews. The DCE survey was completed by patients with a history of periodontal disease. Preferences were elicited for the attributes “tooth loss within next 10 years”, “own costs for treatment, follow-up visits, re-treatment”, “complaints and symptoms”, and “frequency of follow-up visits”. Patients completed a self-administered questionnaire including 12 choice tasks. Data were analyzed using a random parameters logit model. The relative attribute importance was calculated based on level ranges. RESULTS: Within 3 months, survey development, data collection among 267 patients, data analysis, and provision of a study report could be completed. The analysis showed that tooth loss (score 0.73) was the most important attribute in patients’ decisions, followed by complaints and symptoms (0.22), frequency of follow-up visits (0.02), and costs (0.03) (relative importance scores summing up to 1). CONCLUSION: A preference analysis performing a DCE can be generally feasible within 3 months; however, a good research infrastructure and access to patients is required. Outcomes used in benefit assessments might need to be adapted to be used in preference analyses.
format Online
Article
Text
id pubmed-6248230
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62482302018-12-03 Patients’ preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study Vennedey, Vera Derman, Sonja HM Hiligsmann, Mickaël Civello, Daniele Schwalm, Anja Seidl, Astrid Scheibler, Fülöp Stock, Stephanie Noack, Michael J Danner, Marion Patient Prefer Adherence Original Research BACKGROUND AND PURPOSE: The German Institute for Quality and Efficiency in Health Care (IQWiG) previously tested two preference elicitation methods in pilot projects and regarded them as generally feasible for prioritizing outcome-specific results of benefit assessment. The present study aimed to investigate the feasibility of completing a discrete choice experiment (DCE) within 3 months and to determine the relative importance of attributes of periodontal disease and its treatment. PATIENTS AND METHODS: This preference elicitation was conducted alongside the IQWiG benefit assessment of systematic treatments of periodontal diseases. Attributes were defined based on the benefit assessment, literature review, and patients’ and periodontologists’ interviews. The DCE survey was completed by patients with a history of periodontal disease. Preferences were elicited for the attributes “tooth loss within next 10 years”, “own costs for treatment, follow-up visits, re-treatment”, “complaints and symptoms”, and “frequency of follow-up visits”. Patients completed a self-administered questionnaire including 12 choice tasks. Data were analyzed using a random parameters logit model. The relative attribute importance was calculated based on level ranges. RESULTS: Within 3 months, survey development, data collection among 267 patients, data analysis, and provision of a study report could be completed. The analysis showed that tooth loss (score 0.73) was the most important attribute in patients’ decisions, followed by complaints and symptoms (0.22), frequency of follow-up visits (0.02), and costs (0.03) (relative importance scores summing up to 1). CONCLUSION: A preference analysis performing a DCE can be generally feasible within 3 months; however, a good research infrastructure and access to patients is required. Outcomes used in benefit assessments might need to be adapted to be used in preference analyses. Dove Medical Press 2018-11-16 /pmc/articles/PMC6248230/ /pubmed/30510407 http://dx.doi.org/10.2147/PPA.S176067 Text en © 2018 Vennedey et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Vennedey, Vera
Derman, Sonja HM
Hiligsmann, Mickaël
Civello, Daniele
Schwalm, Anja
Seidl, Astrid
Scheibler, Fülöp
Stock, Stephanie
Noack, Michael J
Danner, Marion
Patients’ preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study
title Patients’ preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study
title_full Patients’ preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study
title_fullStr Patients’ preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study
title_full_unstemmed Patients’ preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study
title_short Patients’ preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study
title_sort patients’ preferences in periodontal disease treatment elicited alongside an iqwig benefit assessment: a feasibility study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248230/
https://www.ncbi.nlm.nih.gov/pubmed/30510407
http://dx.doi.org/10.2147/PPA.S176067
work_keys_str_mv AT vennedeyvera patientspreferencesinperiodontaldiseasetreatmentelicitedalongsideaniqwigbenefitassessmentafeasibilitystudy
AT dermansonjahm patientspreferencesinperiodontaldiseasetreatmentelicitedalongsideaniqwigbenefitassessmentafeasibilitystudy
AT hiligsmannmickael patientspreferencesinperiodontaldiseasetreatmentelicitedalongsideaniqwigbenefitassessmentafeasibilitystudy
AT civellodaniele patientspreferencesinperiodontaldiseasetreatmentelicitedalongsideaniqwigbenefitassessmentafeasibilitystudy
AT schwalmanja patientspreferencesinperiodontaldiseasetreatmentelicitedalongsideaniqwigbenefitassessmentafeasibilitystudy
AT seidlastrid patientspreferencesinperiodontaldiseasetreatmentelicitedalongsideaniqwigbenefitassessmentafeasibilitystudy
AT scheiblerfulop patientspreferencesinperiodontaldiseasetreatmentelicitedalongsideaniqwigbenefitassessmentafeasibilitystudy
AT stockstephanie patientspreferencesinperiodontaldiseasetreatmentelicitedalongsideaniqwigbenefitassessmentafeasibilitystudy
AT noackmichaelj patientspreferencesinperiodontaldiseasetreatmentelicitedalongsideaniqwigbenefitassessmentafeasibilitystudy
AT dannermarion patientspreferencesinperiodontaldiseasetreatmentelicitedalongsideaniqwigbenefitassessmentafeasibilitystudy